Critical Role of Iron in Epoetin Alfa Treatment of Chemotherapy-Associated Anemia

被引:3
|
作者
Gross, Irwin [1 ,2 ]
Farmer, Shannon [3 ,4 ]
Hofmann, Axel [3 ,4 ,5 ]
Ozawa, Sherri [6 ]
Shander, Aryeh [6 ,7 ]
Aapro, Matti [8 ]
机构
[1] Eastern Maine Med Ctr, Bangor, ME 04401 USA
[2] Accumen, San Diego, CA 92121 USA
[3] Univ Western Australia, Nedlands, WA 6009, Australia
[4] Curtin Univ, Perth, WA, Australia
[5] Univ Zurich, Zurich, Switzerland
[6] Englewood Hosp & Med Ctr, Englewood, NJ USA
[7] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[8] IMO Clin Genolier, Genolier, Switzerland
关键词
RECOMBINANT-HUMAN-ERYTHROPOIETIN; STIMULATING AGENTS; CANCER-PATIENTS; OPEN-LABEL; IV IRON; THROMBOSIS; MULTICENTER; DEFICIENCY; MORTALITY;
D O I
10.1200/JCO.2016.67.7377
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:3819 / +
页数:3
相关论文
共 50 条
  • [41] Treatment of cancer- and chemotherapy-associated anemia with ferric carboxymaltose in clinical practice
    Steinmetz, T.
    Tschechne, B.
    Harlin, O.
    Klement, B.
    Franzem, M.
    Wamhoff, J.
    Tech, H.
    Rohrberg, R.
    Marschner, N.
    ONKOLOGIE, 2011, 34 : 304 - 304
  • [42] Prevention of anemia by early intervention with once weekly epoetin alfa during chemotherapy
    Codrington, H.
    Schouwink, J. H.
    Sleeboom, H. P.
    Kerkhofs, L. G. M.
    Wormhoudt, L. W.
    EJC SUPPLEMENTS, 2007, 5 (04): : 148 - 148
  • [43] Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease
    Fishbane, Steven
    Singh, Bhupinder
    Kumbhat, Seema
    Wisemandle, Wayne A.
    Martin, Nancy E.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (08): : 1204 - 1214
  • [44] Response: Epoetin alfa for treatment of anemia in HIV-infected patients
    Henry, DH
    Volberding, PA
    Leitz, G
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (03) : 377 - 378
  • [46] Treatment of Chemotherapy-Induced Anemia Using Epoetin Alfa Biosimilar for Patients with Lymphoma and Myeloma: The Synergy Study
    Scotte, Florian
    Laribi, Kamel
    Gisselbrecht, Christian
    Spaeth, Dominique
    Kasdaghli, Emna
    Albrand, Helene
    Leutenegger, Eric
    Ray-Coquard, Isabelle
    BLOOD, 2015, 126 (23)
  • [47] Comparison of anemia treatment outcomes in patients with cancer receiving epoetin alfa and darbepoetin alfa.
    Fahrbach, KR
    Frame, D
    Scheye, R
    Fastenau, JM
    Drielick, M
    Piech, CT
    Nalysnyk, L
    BLOOD, 2003, 102 (11) : 510B - 511B
  • [48] Comment: Epoetin alfa versus darbepoetin alfa for cancer patients with treatment-related anemia
    Yang, MC
    ANNALS OF PHARMACOTHERAPY, 2006, 40 (05) : 998 - 999
  • [49] Epoetin alfa and darbepoetin alfa anemia treatment outcomes in cancer patients from a VA perspective
    Papatheofanis, FJ
    Fastenau, JM
    Chiang, T
    Piech, CT
    VALUE IN HEALTH, 2004, 7 (03) : 246 - 246
  • [50] Anemia and epoetin alfa in high-dose chemotherapy programs for breast cancer patients
    Danova, M
    Ferrari, S
    SEMINARS IN ONCOLOGY, 2002, 29 (03) : 21 - 25